Edition:
United Kingdom

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

5.65USD
22 Jan 2019
Change (% chg)

$-0.06 (-1.05%)
Prev Close
$5.71
Open
$5.74
Day's High
$5.74
Day's Low
$5.55
Volume
38,565
Avg. Vol
32,254
52-wk High
$11.30
52-wk Low
$4.50

Chart for

About

Seres Therapeutics, Inc. is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The Company's drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The Company is focused on... (more)

Overall

Beta: --
Market Cap(Mil.): $482.91
Shares Outstanding(Mil.): 40.51
Dividend: --
Yield (%): --

Financials

  MCRB.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -2.42 -- --
ROI: -41.51 8.99 14.48
ROE: -76.34 10.14 15.99

BRIEF-Seres Therapeutics Announces Initiation Of Ser-287 Phase 2B Eco-Reset Clinical Study For Ulcerative Colitis

* SERES THERAPEUTICS ANNOUNCES INITIATION OF SER-287 PHASE 2B ECO-RESET CLINICAL STUDY FOR ULCERATIVE COLITIS

03 Jan 2019

Earnings vs. Estimates